Nitric oxide does not mediate but inhibits transformation and tumor phenotype

Molecular Cancer Therapeutics

Volumn 2, Issue 12, 2003, Pages 1285-1293

  Dhar, Arindam ^a   Brindley, June M ^a   Stark, Cristi ^a,c   Citro, Michael L ^b   Keefer, Larry K ^a   Colburn, Nancy H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, MOUSE; PHORBOL 13 ACETATE 12 MYRISTATE; PRIMER DNA; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; APOPTOSIS; ARTICLE; CELL LINE; CELL TRANSFORMATION; DRUG ANTAGONISM; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PHYSIOLOGY; TRANSACTIVATION;

ANIMALS; APOPTOSIS; BASE SEQUENCE; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; DNA PRIMERS; MICE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PHENOTYPE; REACTIVE OXYGEN SPECIES; TETRADECANOYLPHORBOL ACETATE; TRANS-ACTIVATION (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 4444361445     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Dalton, T. P., Shertzer, H. G., and Puga, A. Regulation of gene expression by reactive oxygen. Annu. Rev. Pharmacol. Toxicol., 39: 67-101, 1999. (Pubitemid 29222552)
2. Marshall, H. E., Merchant, K., and Stamler, J. S. Nitrosation and oxidation in the regulation of gene expression. FASEB J., 14: 1889-1900, 2000.
3. Stamler, J. S., Lamas, S., and Fang, F. C. Nitrosylation. The prototypic redox-based signaling mechanism. Cell, 106: 675-683, 2001. (Pubitemid 32900659)
4. Forman, H. J., Torres, M., and Fukuto, J. Redox signaling. Mol. Cell. Biochem., 234 - 235: 49-62, 2002.
5. Nathan, C. and Xie, Q. W. Nitric oxide synthases: roles, tolls, and controls. Cell, 78: 915-918, 1994. (Pubitemid 24292319)
6. Alderton, W. K., Cooper, C. E., and Knowles, R. G. Nitric oxide synthases: structure, function and inhibition. Biochem. J., 357: 593-615, 2001. (Pubitemid 32735142)
7. Ducrocq, C., Blanchard, B., Pignatelli, B., and Ohshima, H. Peroxynitrite: an endogenous oxidizing and nitrating agent. Cell. Mol. Life Sci., 55: 1068-1077, 1999. (Pubitemid 29361073)
8. Wink, D. A., Miranda, K. M., Espey, M. G., Pluta, R. M., Hewett, S. J., Colton, C., Vitek, M., Feelisch, M., and Grisham, M. B. Mechanisms of the antioxidant effects of nitric oxide. Antioxid. Redox Signal., 3: 203-213, 2001. (Pubitemid 32473337)
9. Kroncke, K. D., Fehsel, K., Suschek, C., and Kolb-Bachofen, V. Inducible nitric oxide synthase-derived nitric oxide in gene regulation, cell death and cell survival. Int. Immunopharmacol., 1: 1407-1420, 2001. (Pubitemid 32622787)
10. Lala, P. K. and Chakraborty, C. Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol., 2: 149-156, 2001. (Pubitemid 33585926)
11. Thomsen, L. L., Miles, D. W., Happerfield, L., Bobrow, L. G., Knowles, R. G., and Moncada, S. Nitric oxide synthase activity in human breast cancer. Br. J. Cancer, 72: 41-44, 1995.
12. Fu, S., Ramanujam, K. S., Wong, A., Fantry, G. T., Drachenberg, C. B., James, S. P., Meltzer, S. J., and Wilson, K. T. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology, 116: 1319-1329, 1999. (Pubitemid 29258880)
13. Jenkins, D. C., Charles, I. G., Thomsen, L. L., Moss, D. W., Holmes, L. S., Baylis, S. A., Rhodes, P., Westmore, K., Emson, P. C., and Moncada, S. Roles of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. USA, 92: 4392-4396, 1995.
14. Liu, C. Y., Wang, C. H., Chen, T. C., Lin, H. C., Yu, C. T., and Kuo, H. P. Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer. Br. J. Cancer, 78: 534-541, 1998.
15. Klotz, T., Bloch, W., Volberg, C., Engelmann, U., and Addicks, K. Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Cancer, 82: 1897-1903, 1998. (Pubitemid 28208645)
16. Massi, D., Franchi, A., Sardi, I., Magnelli, L., Paglierani, M., Borgognoni, L., Maria Reali, U., and Santucci, M. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions. J. Pathol., 194: 194-200, 2001. (Pubitemid 32519969)
17. Kagoura, M., Matsui, C., Toyoda, M., and Morohashi, M. Immunohistochemical study of inducible nitric oxide synthase in skin cancers. J. Cutan. Pathol., 28: 476-481, 2001. (Pubitemid 32881885)
18. Thomsen, L. L., Lawton, F. G., Knowles, R. G., Beesley, J. E., Riveros-Moreno, V., and Moncada, S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res., 54: 1352-1354, 1994. (Pubitemid 24108080)
19. Ambs, S., Merriam, W. G., Bennett, W. P., Felley-Bosco, E., Ogunfusika, M. O., Oser, S. M., Klein, S., Shields, P. G., Billiar, T. R., and Harris, C. C. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res., 58: 334-341, 1998. (Pubitemid 28047076)
20. Ahn, B. and Ohshima, H. Suppression of intestinal polyposis in Apc(Min/+) mice by inhibiting nitric oxide production. Cancer Res., 61: 8357-8360, 2001. (Pubitemid 33131104)
21. Rao, C. V., Indranie, C., Simi, B., Manning, P. T., Connor, J. R., and Reddy, B. S. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Cancer Res., 62: 165-170, 2002. (Pubitemid 34074001)
22. Xie, K., Huang, S., Dong, Z., Juang, S. H., Gutman, M., Xie, Q. W., Nathan, C., and Fidler, I. J. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J. Exp. Med., 181: 1333-1343, 1995.
23. Xie, K., Dong, Z., and Fidler, I. J. Activation of nitric oxide synthase gene for inhibition of cancer metastasis. J. Leukoc. Biol., 59: 797-803, 1996. (Pubitemid 26238474)
24. Juang, S. H., Xie, K., Xu, L., Shi, Q., Wang, Y., Yoneda, J., and Fidler, I. J. Suppression of tumorigenicity and metastasis of human renal carcinoma cells by infection with retroviral vectors harboring the murine inducible nitric oxide synthase gene. Hum. Gene Ther., 9: 845-854, 1998. (Pubitemid 28197371)
25. Tretyakova, N. Y., Burney, S., Pamir, B., Wishnok, J. S., Dedon, P. C., Wogan, G. N., and Tannenbaum, S. R. Peroxynitrite-induced DNA damage in the supF gene: correlation with the mutational spectrum. Mutat. Res., 447: 287-303, 2000. (Pubitemid 30177176)
26. Zhuang, J. C., Lin, C., Lin, D., and Wogan, G. N. Mutagenesis associated with nitric oxide production in macrophages. Proc. Natl. Acad. Sci. USA, 95: 8286-8291, 1998. (Pubitemid 28326105)
27. Ambs, S., Bennett, W. P., Merriam, W. G., Ogunfusika, M. O., Oser, S. M., Harrington, A. M., Shields, P. G., Felley-Bosco, E., Hussain, S. P., and Harris, C. C. Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer. J. Natl. Cancer Inst., 91: 86-88, 1999. (Pubitemid 29042448)
28. Calmels, S., Hainaut, P., and Ohshima, H. Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein. Cancer Res., 57: 3365-3369, 1997. (Pubitemid 27355476)
29. Chazotte-Aubert, L., Hainaut, P., and Ohshima, H. Nitric oxide nitrates tyrosine residues of tumor-suppressor p53 protein in MCF-7 cells. Biochem. Biophys. Res. Commun., 267: 609-613, 2000. (Pubitemid 30076846)
30. Mordan, L. J., Burnett, T. S., Zhang, L. X., Tom, J., and Cooney, R. V. Inhibitors of endogenous nitrogen oxide formation block the promotion of neoplastic transformation in C3H 10T1/2 fibroblasts. Carcinogenesis, 14: 1555-1559, 1993. (Pubitemid 23249358)
31. Trikha, P., Sharma, N., and Athar, M. Nitroglycerin: a NO donor inhibits TPA-mediated tumor promotion in murine skin. Carcinogenesis, 22: 1207-1211, 2001. (Pubitemid 32737337)
32. Dhar, A., Young, M. R., and Colburn, N. H. The role of AP-1, NF-κB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive. Mol. Cell. Biochem., 234-235: 185-193, 2002. (Pubitemid 34777856)
33. Colburn, N. H., Former, B. F., Nelson, K. A., and Yuspa, S. H. Tumour promoter induces anchorage independence irreversibly. Nature, 281: 589-591, 1979. (Pubitemid 10242874)
34. Colburn, N. H., Gindhart, T. D., Hegamyer, G. A., Blumberg, P. M., Delclos, K. B., Magun, B. E., and Lockyer, J. Phorbol diester and epidermal growth factor receptors in 12-O -tetradecanoylphorbol-13-acetate-resistant and -sensitive mouse epidermal cells. Cancer Res., 42: 3093-3097, 1982. (Pubitemid 12041060)
35. Bernstein, L. R. and Colburn, N. H. AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells. Science, 244: 566-569, 1989. (Pubitemid 19140808)
36. Bernstein, L. R., Bravo, R., and Colburn, N. H. 12-O- tetradecanoylphorbol-13-acetate-induced levels of AP-1 proteins: a 46-kDa protein immunoprecipitated by anti-fra-1 and induced in promotion-resistant but not promotion-sensitive JB6 cells. Mol. Carcinog., 6: 221-229, 1992.
37. Bernstein, L. R., Ferris, D. K., Colburn, N. H., and Sobel, M. E. A family of mitogen-activated protein kinase-related proteins interacts in vivo with activator protein-1 transcription factor. J. Biol. Chem., 269: 9401-9404, 1994. (Pubitemid 24196525)
38. Huang, C., Ma, W. Y., Young, M. R., Colburn, N., and Dong, Z. Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells. Proc. Natl. Acad. Sci. USA, 95: 156-161, 1998. (Pubitemid 28103923)
39. Watts, R. G., Huang, C., Young, M. R., Li, J. J., Dong, Z., Pennie, W. D., and Colburn, N. H. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation. Oncogene, 17: 3493-3498, 1998. (Pubitemid 29050684)
40. Hsu, T-C., Nair, R., Tulsian, P., Hegamyer, G., Young, M. R., and Colburn, N. H. Transformation non-responsive cells owe their resistance to lack of NF-κB activation. Cancer Res., 61: 4160-4168, 2001. (Pubitemid 32720985)
41. Young, M. R., Nair, R., Bucheimer, N., Tulsian, P., Brown, N., Chapp, C., Hsu, T. C., and Colburn, N. H. Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently. Mol. Cell. Biol., 22: 587-598, 2002. (Pubitemid 34027503)
42. Nakamura, Y., Colburn, N. H., and Gindhart, T. D. Role of reactive oxygen in tumor promotion: implication of superoxide anion in promotion of neoplastic transformation in JB-6 cells by TPA. Carcinogenesis, 6: 229-235, 1985. (Pubitemid 15172799)
43. Amstad, P. A., Liu, H., Ichimiya, M., Berezesky, I. K., and Trump, B. F. Manganese superoxide dismutase expression inhibits soft agar growth in JB6 clone41 mouse epidermal cells. Carcinogenesis, 18: 479-484, 1997. (Pubitemid 28132483)
44. Zhao, Y., Xue, Y., Oberley, T. D., Kiningham, K. K., Lin, S. M., Yen, H. C., Majima, H., Hines, J., and St Clair, D. Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model. Cancer Res., 61: 6082-6088, 2001. (Pubitemid 32762543)
45. Murakami, A., Kawabata, K., Koshiba, T., Gao, G., Nakamura, Y., Koshimizu, K., and Ohigashi, H. Nitric oxide synthase is induced in tumor promoter-sensitive, but not tumor promoter-resistant, JB6 mouse epidermal cells cocultured with interferon-γ-stimulated RAW 264.7 cells: the role of tumor necrosis factor-α. Cancer Res., 60: 6326-6331, 2000.
46. Chomczynski, P. and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987. (Pubitemid 17064313)
47. Keefer, L. K., Nims, R. W., Davies, K. M., and Wink, D. A. "NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol., 268: 281-293, 1996. (Pubitemid 26286370)
48. Li, J. J., Westergaard, C., Ghosh, P., and Colburn, N. H. Inhibitors of both nuclear factor-κB and activator protein-1 activation block the neoplastic transformation response. Cancer Res., 57: 3569-3576, 1997. (Pubitemid 27355509)
49. Chu, S. C., Marks-Konczalik, J., Wu, H. P., Banks, T. C., and Moss, J. Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: characterization of differences between human and mouse iNOS promoters. Biochem. Biophys. Res. Commun., 248: 871-878, 1998. (Pubitemid 28404515)
50. Reif, D. W. and McCreedy, S. A. N-nitro-L-arginine and N-monomethyl-L-arginine exhibit a different pattern of inactivation toward the three nitric oxide synthases. Arch. Biochem. Biophys., 320: 170-176, 1995.
51. Garvey, E. P., Oplinger, J. A., Furfine, E. S., Kiff, R. J., Laszlo, F., Whittle, B. J., and Knowles, R. G. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo . J. Biol. Chem., 272: 4959-4963, 1997. (Pubitemid 27090046)
52. Dion, L. D., Gindhart, T. D., and Colburn, N. H. Four-day duration of tumor promoter exposure required to transform JB6 promotion-sensitive cells to anchorage independence. Cancer Res., 48: 7126-7131, 1988. (Pubitemid 19013993)
53. Wink, D. A. and Mitchell, J. B. Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic. Biol. Med., 25: 434-456, 1998. (Pubitemid 28390299)
54. Hofseth, L. J., Hussain, S. P., Wogan, G. N., and Harris, C. C. Nitric oxide in cancer and chemoprevention. Free Radic. Biol. Med., 34: 955-968, 2003. (Pubitemid 36398556)
55. Scott, D. J., Hull, M. A., Cartwright, E. J., Lam, W. K., Tisbury, A., Poulsom, R., Markham, A. F., Bonifer, C., and Coletta, P. L. Lack of inducible nitric oxide synthase promotes intestinal tumorigenesis in the Apc(Min/+) mouse. Gastroenterology, 121: 889-899, 2001. (Pubitemid 32959398)
56. Marshall, H. E. and Stamler, J. S. Inhibition of NF-κB by Snitrosylation. Biochemistry, 40: 1688-1693, 2001.
57. Marshall, H. E. and Stamler, J. S. Nitrosative stress-induced apoptosis through inhibition of NF-κB. J. Biol. Chem., 277: 34223-34228, 2002.
58. Moore, R. J., Owens, D. M., Stamp, G., Arnott, C., Burke, F., East, N., Holdsworth, H., Turner, L., Rollins, B., Pasparakis, M., Kollias, G., and Balkwill, F. Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis. Nat. Med., 5: 828-831, 1999. (Pubitemid 29318619)